BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-08-02
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 21
- Registration Number
- NCT00206388
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Indiana University-Riley Children's Hospital, Indianapolis, Indiana, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
Ability to Cope With Type 1 Diabetes
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 220
- Registration Number
- NCT00206349
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
The Role of Amylin and Glucagon in T1DM
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT00206258
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT00206297
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
A Randomized, Placebo-controlled, Tourette Syndrome Study.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2020-02-12
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 29
- Registration Number
- NCT00206323
Lantus in the Treatment of Type 1 Diabetes Children
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT00206401
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2020-10-30
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 16
- Registration Number
- NCT00206375
- Locations
- 🇺🇸
Baylor college of Medicine, Houston, Texas, United States
An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT00206336
Ability to Cope With Type 1 Diabetes
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 100
- Registration Number
- NCT00206362
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Physician Uncertainty Reduction for Hypertension
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-07-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 670
- Registration Number
- NCT00201084
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath